Using a limited sampling strategy to investigate the interindividual pharmacokinetic variability in metformin: A large prospective trial-Reference-Cited by-同舟云学术

Using a limited sampling strategy to investigate the interindividual pharmacokinetic variability in metformin: A large prospective trial

Published:2020-11-13 Issue:4 Volume:87 Page:1963-1969
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kuhlmann Ida¹,Arnspang Pedersen Sidsel,Skov Esbech Peter²^ORCID,Bjerregaard Stage Tore¹^ORCID,Hougaard Christensen Mette Marie²³,Brøsen Kim¹⁴^ORCID

Affiliation:

1. Clinical Pharmacology and Pharmacy, Department of Public Health University of Southern Denmark Odense Denmark

2. Department of Clinical Biochemistry and Pharmacology Odense University Hospital Odense Denmark

3. Department of Clinical Research University of Southern Denmark Odense Denmark

4. OPEN, Odense Patient data Explorative Network Odense University Hospital Odense Denmark

Funder

Det Frie Forskningsråd

Syddansk Universitet

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14591

Reference30 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2. The pharmacogenetics of metformin

3. ClinicalTrials.gov ‐ metformin [Internet].www.clinicaltrials.gov; Tilgængelig hos:https://clinicaltrials.gov/ct2/results?term=metformin&Search=Apply&recrs=h&r

4. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

5. Transporters Involved in Metformin Pharmacokinetics and Treatment Response

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of GLUT2 rs8192675, MATE1 rs2289669, and OCT2 rs316019 Genetic Polymorphism on Metformin Efficacy and Glycemic Control in Type 2 Diabetes Mellitus Patients;2024-02-16

2. Genetic polymorphism of organic cation transporter 2 (OCT2) and its effects on the pharmacokinetics and pharmacodynamics of Metformin: a narrative review;Egyptian Journal of Medical Human Genetics;2023-01-24

3. Metformin—‘BRAINS & AIMS’ pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion;British Journal of Clinical Pharmacology;2023-01-23

4. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation;Pharmacology & Therapeutics;2022-10

5. Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance;2022-05-24